Patents Assigned to University School of Medicine
-
Patent number: 11957896Abstract: Provided is an intraesophageal electrostimulator configured so that other medical tools can also be easily inserted into an esophagus and misalignment in the esophagus can be reduced. An intraesophageal electrostimulator 100 includes a stimulator body 101, stimulating electrodes 111, 112, and power feed lines 113, 114. The stimulator body 101 is formed, in order to insert the stimulator body 101 into an esophagus S, in an elongated flat plate shape with flexibility in a longitudinal direction. The stimulator body 101 includes a first flat plate member 102, a second flat plate member 103, and an exterior body 104. On one plate surface of the first flat plate member 102, each of the stimulating electrodes 111, 112 is provided so as to protrude from the plate surface. The second flat plate member 103 overlaps with the other plate surface of the first flat plate member 102 such that the second flat plate member 103 and the first flat plate member 102 sandwich the power feed lines 113, 114.Type: GrantFiled: December 9, 2021Date of Patent: April 16, 2024Assignee: Hamamatsu University School of MedicineInventor: Norihiko Shiiya
-
Publication number: 20240115658Abstract: A use of an intervertebral disc fibrosis-inducing substance in preparation of medication, where the medication is used for the treatment of degenerative spinal diseases. The inventors of the present disclosure make use of the pro-fibrotic effect of the intervertebral disc fibrosis-inducing substance and the auxiliary effect of the fibroblast to achieve further treatment of intervertebral disc degeneration. The simultaneous administration of the above two drugs can reasonably control the degeneration and achieve the purpose of stepped treatment, thereby having clinical transformation value. In addition, the therapy combining the intervertebral disc fibrosis-inducing substance with the cell in the present disclosure allows the treatment regimen more personalized.Type: ApplicationFiled: June 11, 2021Publication date: April 11, 2024Applicant: Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of MedicineInventors: Jie ZHAO, Chen CHEN, Xiao YANG, Tangjun ZHOU, An QIN, Zhiqian CHEN, Kai ZHANG, Yifan ZHOU
-
Publication number: 20240069027Abstract: A use of nitrogen-doped carbon fluorescent quantum dots in preparation of aerobic glycolysis detection products is provided. The carbon-nitrogen fluorescent quantum dots are selected from one or more of C3N4 quantum dots, C2N quantum dots, and C3N quantum dots. The aerobic glycolysis detection products are reagents, based on a final volume of the reagents, the reagents comprise the carbon-nitrogen fluorescent quantum dots with a final concentration of 1 ?g/mL-1 mg/mL. The present disclosure realizes fluorescent labeling of NAD+ in living cells using the carbon-nitrogen fluorescent quantum dots, thus achieving fluorescent labeling and imaging of cells having aerobic glycolysis, which has the advantages of low cost, high efficiency, rapidity, and high accuracy.Type: ApplicationFiled: December 28, 2021Publication date: February 29, 2024Applicants: SHANGHAI NINTH PEOPLE'S HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE, SHANGHAI INSTITUTE OF MICROSYSTEM AND INFORMATION TECHNOLOGY, CHINESE ACADEMY OF SCIENCESInventors: JIPENG LI, SIWEI YANG, GUQIAO DING, HUIFANG ZHOU, XIANQUN FAN
-
Patent number: 11913042Abstract: Methods of preparing and using a highly active blood coagulation factor XI mutant and a gene therapy/editing vector thereof and a recombinant/fusion protein thereof. The nucleotide sequence of the mutant is as shown in SEQ ID NOs: 1-6, and the amino acid sequence is as shown in SEQ ID NO: 7.Type: GrantFiled: August 30, 2018Date of Patent: February 27, 2024Assignees: RUIJIN HOSPITAL SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINEInventors: Xuefeng Wang, Wenman Wu, Qiulan Ding
-
Publication number: 20240042109Abstract: A preparation method of drug-loaded micelles of an absorbable vascular stent coating for angiostenosis in an infant is provided, including the following steps: Si: dissolving a drug to be encapsulated in an appropriate amount of an emulsifying agent, adding a chitosan-poly(p-dioxohone) amphiphilic block copolymer (chitosan-b-PPDO copolymer), and thoroughly mixing to obtain a drug-copolymer solution; S2: adding the drug-copolymer solution obtained in S1 dropwise to an emulsifying agent aqueous solution prepared in advance, and continuously stirring to obtain a stable drug-loaded micellar solution; and S3: removing the emulsifying agent from the micellar solution obtained in S2 through vacuum evaporation, stirring a resulting concentrate, and centrifuging the concentrate to obtain a supernatant; and filtering the supernatant to obtain a filtrate, and subjecting the filtrate to dialysis to obtain the drug-loaded micelles.Type: ApplicationFiled: March 29, 2022Publication date: February 8, 2024Applicant: XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINEInventors: Kun SUN, Jing SUN, Sun CHEN, Kai BAI, Yanan LU, Lu WANG, Fujun WANG, Fan ZHAO, Jihong HUANG
-
Publication number: 20230404763Abstract: A muscle function preservation type total temporomandibular joint prosthesis includes an articular fossa member (1) and an articular head member (2) abutting against the articular fossa member (1). The articular head member (2) includes a mandibular trailing edge fixing plate (21), a sigmoid notch fixing plate (22) and an articular head portion (23). The mandibular trailing edge fixing plate (21) is connected to a bottom end of the articular head portion (23) and extends downwards, and has a plate-shaped structure and includes a mandibular-trailing-edge-surface attaching surface. The sigmoid notch fixing plate (22) protrudes from one side of the mandibular trailing edge fixing plate (21) and extends in a direction away from the mandibular trailing edge fixing plate (21), and has a plate-shaped structure and includes a mandibular-ramus-proximal-sigmoid-notch-portion attaching surface.Type: ApplicationFiled: November 18, 2020Publication date: December 21, 2023Applicant: SHANGHAI NINTH PEOPLE'S HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINEInventors: CHI YANG, JISI ZHENG, ZIXIAN JIAO, MINJIE CHEN, WENBO JIANG
-
Publication number: 20230398071Abstract: The present invention relates to the field of hemodialysis and peritoneal dialysis, in particular to a fat emulsion dialysate, and preparation method and the use thereof. Provided in the present invention is a fat emulsion dialysate, comprising a long-chain fat emulsion oil, a medium-chain triglyceride, an anti-oxidant, sodium oleate, glycerin, phospholipid, and a solvent. Compared with traditional dialysis, the fat emulsion dialysate provided by the present invention has a better advantage for protein-bound toxin removal. In addition, the fat emulsion dialysate not only has a simple preparation method and a low cost, but also has good stability and safety, and remains stable at room temperature for 14 days without obvious precipitation. Thus, the fat emulsion dialysate can become a hemodialysis dialysate or peritoneal dialysate with broad application prospects, and has good industrialization prospects.Type: ApplicationFiled: July 5, 2023Publication date: December 14, 2023Applicant: Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of MedicineInventors: Feng DING, Yifeng WANG, Yuqi SHEN, Jiaolun LI
-
Patent number: 11805992Abstract: The present invention discloses an auxiliary visible light rod for multisource end-expiratory CO2 monitoring. The auxiliary visible light rod comprises a handle, a pump body, a medicine compartment, a rod body and a bracket. The handle is separately connected with the medicine compartment, the pump body and the rod body, and one end of the rod body is connected with a rod head. A lamp and an atomizing head are arranged in the rod head. A circuit tube is connected with the external wall of the rod body, one end of the circuit tube is connected with a display screen, and the other end of the circuit tube is connected with a camera in the rod head. The bracket sleeves the rod body and is fixed to the outer side of an oral cavity or a chin of a patient, and thus the stability of the rod body is improved.Type: GrantFiled: December 10, 2020Date of Patent: November 7, 2023Assignee: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of MedicineInventors: Hong Jiang, Ming Xia, Yu Sun, Jia Yan
-
Publication number: 20230338219Abstract: An intelligent mouth opening rehabilitation device is provided, including: a body, an end of the body is provided with an upper bite pad and a lower bite pad; a pressure sensor, for detecting pressure data on the upper bite pad and/or the lower bite pad; a stepping motor, for driving the upper bite pad and/or the lower bite pad to swing longitudinally; and a processor, for controlling the stepping motor to operate or stop according to the pressure data and/or a preset training instruction, thereby driving the upper bite pad and/or the lower bite pad to swing longitudinally or to stop. Compared with traditional mouth opening rehabilitation devices, the intelligent mouth opening rehabilitation device controls automatically the upper bite pad and/or the lower bite pad to swing longitudinally, so that a mouth opening training is more accurate, and more controllable. Therefore, a rehabilitation effect is greatly improved.Type: ApplicationFiled: July 27, 2021Publication date: October 26, 2023Applicant: Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of MedicineInventors: Jiannan LIU, Guangtao ZHAI, Chenping ZHANG, Zhiyuan ZHANG
-
Publication number: 20230338479Abstract: A high-activity blood coagulation factor XI mutant Ala570Thr (A570T), having nucleotide sequences as shown in SEQ ID NOs: 1-4 and an amino acid sequence as shown in SEQ ID NO: 5, is provided. The mutant is resistant to a physiological inhibitor thereof after being activated from a zymogen state to an active enzyme. Therefore, the mutant has a very high blood coagulation activity and a stronger catalytic ability for a non-physiological substrate; and the mutant is applied to the treatment of hemorrhagic diseases, and has good prospects in terms of gene therapy, gene editing and recombinant protein replacement treatments.Type: ApplicationFiled: April 13, 2021Publication date: October 26, 2023Applicants: RUIJIN HOSPITAL SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINEInventors: Wenman WU, Xuefeng WANG, Qiulan DING
-
Patent number: 11786682Abstract: An end-expiratory CO2 guided tracheal intubation apparatus includes: an intubation tube, an end-expiratory CO2 catheter, a suction tube, an airbag and an inflation tube. The end-expiratory CO2 catheter partially penetrates the sidewall of the intubation tube, one end of the end-expiratory CO2 catheter extends beyond an end of the intubation tube, and the other end is connected to an end-expiratory CO2 sensor, the suction tube partially penetrates a sidewall of the intubation tube, one end of the liquid suction tube extends beyond an end of the intubation tube, the other end is connected to an air pump, the airbag sleeves the outer wall of the intubation tube, the inflation tube partially penetrates the sidewall of the intubation tube, one end thereof is connected to the airbag, and the other end is connected to the air supply device.Type: GrantFiled: December 11, 2020Date of Patent: October 17, 2023Assignee: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of MedicineInventors: Hong Jiang, Ming Xia, Yu Sun, Jia Yan
-
Publication number: 20230321284Abstract: The present invention relates to a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof. In the formula (1), R1 to R3 are each independently a predetermined amino group or a predetermined amide group, or a group represented by the formula (2), and at least one of R1 to R3 is a group represented by the formula (2).Type: ApplicationFiled: April 12, 2021Publication date: October 12, 2023Applicants: ST. MARIANNA UNIVERSITY SCHOOL OF MEDICINE, SOPHIA SCHOOL CORPORATIONInventors: Nobuyuki MATSUMOTO, Yumiko SUZUKI
-
Patent number: 11779429Abstract: A medical instrument display includes an image storage that stores a plurality of image data of a medical instrument, a data analyzer that searches a plurality of image data stored in the image storage on a certain condition, and a display controller that causes a display to display a first medical instrument image that has been selected from thumbnail images, the thumbnail images being based on a plurality of the image data obtained by the search, and a second medical instrument image in good order, the second medical instrument image being different from the first medical instrument image.Type: GrantFiled: October 3, 2022Date of Patent: October 10, 2023Assignees: ROLAND DG CORPORATION, HAMAMATSU UNIVERSITY SCHOOL OF MEDICINEInventors: Masaki Hanajima, Takaaki Kokubo, Takeshi Tsuji, Akinori Sugaya, Naomi Ishino
-
Patent number: 11771805Abstract: An injectable in situ pore-forming hydrogel system and its preparation method and use are provided. The injectable in situ pore-forming hydrogel system uses an injectable hydrogel as a continuous base phase, and isolated live cells and magnesium particles are distributed in the continuous base phase, where the injectable hydrogel is a precursor or prepolymer of hydrogel, which can form hydrogel by cross-linking. The injectable in situ pore-forming hydrogel system can be used to create pores while the gel encapsulates live cells, which makes use of both the injectability and porous structures of hydrogel, which is important for the repair of cavitary, surgically difficult and irregularly defective tissues; meanwhile, magnesium particles generate magnesium ions after the former undergoes gas production and degradation, which can improve the bioactivity of the gel and aid in tissue repair.Type: GrantFiled: July 7, 2020Date of Patent: October 3, 2023Assignee: Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of MedicineInventors: Xinquan Jiang, Wenjie Zhang, Yanmei Tang, Sihan Lin
-
Patent number: 11771656Abstract: An oral colon-targeted delivery system is described, which includes a bacterial flora sensitive layer which contains polysaccharides and covers the exterior of active ingredients, a pH sensitive layer which contains any polymer composition dissolved under the condition of pH?7 and covers the exterior of the bacterial flora sensitive layer. A preparation method and applications of the delivery system are also described. According to the oral colon-targeted delivery system combined with the pH sensitive and bacterial flora sensitive mechanisms, the selective dissolution and release of active ingredients in the colon site are effectively improved by using double-layer protection so that the therapeutic or diagnostic effect is enhanced, and the application prospect is broad.Type: GrantFiled: November 17, 2016Date of Patent: October 3, 2023Assignee: Shanghai Jiaotong University School of MedicineInventors: Zeyu Xiao, Lei Lu, Gaoxian Chen, Miao Lin
-
Publication number: 20230258632Abstract: The present invention provides a highly sensitive immunochromatography measurement method in which a labeling substance for labeling an object to be detected in a specimen undergoing immunochromatography is quantified by being identified with precision, high resolution, and increased contrast using an electron microscope. An immunochromatography measurement method according to an embodiment of the present invention is characterized in that measurement is performed by an electron microscope after applying an auxiliary liquid other than a specimen in the immunochromatography.Type: ApplicationFiled: April 8, 2021Publication date: August 17, 2023Applicants: NATIONAL UNIVERSITY CORPORATION HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE, NANOSUIT INCORPORATEDInventors: Hideya KAWASAKI, Takahiko HARIYAMA
-
Publication number: 20230248254Abstract: The present disclosure is related to a system for monitoring microcirculation is provided. The system may include a detector, the detector being inserted under a tongue of a user along a sagittal axis direction of the user; a light source, the light source being disposed on a surface of the detector in contact with a bottom surface of the tongue of the user and being configured to emit a light source signal to a target region under the tongue; and a lens set, the lens set being disposed within the detector for receiving a detection signal from the target region, wherein the detection signal is emitted into the detector along a vertical axis direction of the user and emitted out from the detector along the sagittal axis direction of the user.Type: ApplicationFiled: April 13, 2023Publication date: August 10, 2023Applicants: RUIJIN HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE, SHANGHAI JIAO TONG UNIVERSITYInventors: Buwei YU, Chongzhao WU, Han LU, Xiaomei CHI, Bo CHEN
-
Publication number: 20230245478Abstract: A discrimination device is a device that discriminates whether or not a discrimination target object is a blood cell based on an image of the discrimination target object, and includes a blood cell feature extraction unit that acquires an image of a blood cell and extracts a feature of the blood cell from the acquired image, a discrimination target object feature extraction unit that acquires the image of the discrimination target object and extracts a feature of the discrimination target object from the acquired image, and a discrimination unit that discriminates whether or not the discrimination target object is a blood cell through anomaly detection based on the extracted feature of the blood cell and the feature of the discrimination target object.Type: ApplicationFiled: June 11, 2021Publication date: August 3, 2023Applicants: HAMAMATSU PHOTONICS K.K., NATIONAL UNIVERSITY CORPORATION HAMAMATSU UNIVERSITY SCHOOL OF MEDICINEInventors: Fumio HASHIMOTO, Kibo OTE, Hidenao YAMADA, Hirotoshi KIKUCHI, Amane HIROTSU, Shigetoshi OKAZAKI
-
Publication number: 20230220042Abstract: Provided is a modified Fc region. The Fc region has at least one amino acid mutation with respect to a parent Fc region. The modified Fc region has improved affinity to Fc?RIIB with respect to the affinity of the parent Fc region to Fc?RIIB Also provided is an antibody containing the modified Fc region, especially an agonistic antibody. The modified Fc region has significant use for optimizing the agonistic activity of the antibody.Type: ApplicationFiled: December 3, 2020Publication date: July 13, 2023Applicant: SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINEInventors: Fubin LI, Yan ZHANG, Mi ZHANG, Yanxia BI, Shihao TIAN, Huihui ZHANG, Shujun LIU
-
Patent number: 11684696Abstract: A gradient mineralized cancellous bone matrix material and a preparation method thereof are provided, and the preparation method includes: processing naturally-derived bone tissue with an immunogenicity removal treatment for decellularization, and processing an obtained decellularzed bone with a gradient demineralization treatment to obtain the gradient mineralized cancellous bone matrix material. The present invention expands a porosity of the bone matrix material and a collagen exposure degree on a surface thereof, which effectively releases growth factors and improves adhesion of the material to the cells, so as to up-regulate genes and proteins related to cell regeneration.Type: GrantFiled: March 12, 2019Date of Patent: June 27, 2023Assignees: SIR RUN RUN SHAW HOSPITAL ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE, ZHEJIANG DISAI BIOTECHNOLOGY CO., LTDInventors: Xianfeng Lin, Shijie Liu, Yiyun Wang, Yazhi Lu, Shunwu Fan